FDA Inspection 1083007 — Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals)
The FDA completed an inspection of Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals) on March 18, 2019 in Houston, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Houston, TX (United States)